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ABSTRACT
Introduction Frailty and pain are associated with adverse 
patient clinical outcomes and healthcare system costs. 
Frailty and pain can interact, such that symptoms of 
frailty can make pain assessment difficult and pain can 
exacerbate the progression of frailty. The prevalence of 
frailty and pain and their concurrence in hospital settings 
are not well understood, and patients with cognitive 
impairment are often excluded from pain prevalence 
studies due to difficulties assessing their pain. The aim 
of this study is to determine the prevalence of frailty and 
pain in adult inpatients, including those with cognitive 
impairment, in an acute care private metropolitan hospital 
in Western Australia.
Methods and analysis A prospective, observational, 
single- day point prevalence, cross- sectional study of 
frailty and pain intensity of all inpatients (excluding day 
surgery and critical care units) will be undertaken. Frailty 
will be assessed using the modified Reported Edmonton 
Frail Scale. Current pain intensity will be assessed 
using the PainChek smart- device application enabling 
pain assessment in people unable to report pain due 
to cognitive impairment. Participants will also provide 
a numerical rating of the intensity of current pain and 
the worst pain experienced in the previous 24 hours. 
Demographic and clinical information will be collected 
from patient files. The overall response rate of the survey 
will be reported, as well as the percentage prevalence of 
frailty and of pain in the sample (separately for PainChek 
scores and numerical ratings). Additional statistical 
modelling will be conducted comparing frailty scores with 
pain scores, adjusting for covariates including age, gender, 
ward type and reason for admission.
Ethics and dissemination Ethical approval has been 
granted by Ramsay Health Care Human Research Ethics 
Committee WA/SA (reference: 2038) and Edith Cowan 
University Human Research Ethics Committee (reference: 
2020–02008- SAUNDERS). Findings will be widely 
disseminated through conference presentations, peer- 
reviewed publications and social media.
Trial registration number ACTRN12620000904976.
INTRODUCTION
The ageing population and increasing 
number of frail older patients presents a chal-
lenge for health services. This patient group 
often have multiple co- morbidities and symp-
toms including pain.1 2 Frailty and pain can 
interact in such a way that symptoms of frailty 
such as cognitive decline can make pain diffi-
cult to assess,3 and pain can exacerbate the 
progression of frailty.4–6 Frailty and pain are 
both associated with negative clinical and 
patient outcomes,7 8 and significant costs to 
the healthcare system,9 10 yet the prevalence 
of each and their occurrence in hospital 
settings are not well understood.1 11 12
Frailty is defined as ‘a medical syndrome 
with multiple causes and contributors that is 
characterised by diminished strength, endur-
ance and reduced physiological function, 
that increases an individual’s vulnerability 
for increased dependency and/or death’ 
Strengths and limitations of this study
 ► This will be the first study to simultaneously assess 
the point prevalence of frailty and pain across all 
inpatients (excluding day surgery and critical care 
wards) in an acute hospital.
 ► The results of this study will inform future use of 
routine frailty assessment and a technology- driven 
assessment of pain.
 ► Technology- driven assessment of pain will enable 
pain intensity levels to be determined for patients 
who cannot verbalise their pain or provide a numer-
ical pain rating and who therefore have previously 
been excluded from prevalence studies.
 ► Exclusion of critical care wards (ie, intensive care 
unit and coronary care unit) mean prevalence across 
the entire hospital cannot be fully determined.
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[Morley, p393].13 Frailty is associated with increased 
risk of postoperative complications, increased length of 
hospital stay, functional dependency post- discharge, read-
mission to hospital and death during hospitalisation.8 14–16 
One study identified an increase in healthcare costs of 
between 54% and 101% concomitant with increasing 
symptoms of frailty and costs of nursing care.9 Clinical 
Practice Guidelines recommend routine frailty screening 
for older adult patients.17
The difficulty in routinely assessing patients for frailty 
and determining its prevalence is in part due to the 
nature, design and administration of the assessment 
tools. Many of the assessment tools such as the pheno-
type model18 are performance- based measures of physical 
function which are lengthy and require specialist admin-
istration. Recently, self- report measures of function have 
been developed, including the Reported Edmonton Frail 
Scale (REFS)19 and the modified REFS (mod- REFS),20 
which have been shown to provide a valid estimate of 
frailty.19 21
A systematic review of community based cohort studies 
estimated 10.7% of the older adult population are cate-
gorised as frail.22 Recent studies suggest the prevalence 
of frailty is higher for hospitalised older adults, reporting 
rates between 28% and 87%.23–28 The large degree of vari-
ability may be, in part, due to differences in the methods 
of assessment of frailty, the lack of standardisation across 
studies, differences in the medical conditions and ward 
type included and variety of geographical locations. The 
focus on older adult patients and/or limitation to specific 
wards makes generalisation difficult and results do not 
provide a complete picture of the hospital- wide preva-
lence of frailty.
Only two studies were located that reported the point 
prevalence of frailty across all patients in an entire hospital. 
Richards et al12 assessed frailty using the mod- REFS and 
found the prevalence to be 48.8% in a tertiary hospital 
in New Zealand. The prevalence of frailty was found 
to increase significantly with age and differences were 
found between admission types (eg, patients admitted to 
a medical specialty were frailer than those admitted to a 
surgical specialty12). Condon et al29 assessed frailty using 
the Clinical Frail Scale30 and reported 52.2% prevalence 
of frailty in an acute university hospital in Ireland. Given 
the focus of the study was on incontinence, associations 
with frailty were not fully explored, however, increased 
frailty scores were associated with both increased urinary 
and faecal incontinence.29 Despite the difference in 
location (ie, New Zealand vs Ireland), these two studies 
suggest that approximately half of all inpatients within 
public hospitals are frail. However, the prevalence of 
frailty across all patients within an Australian hospital 
and within a private hospital setting has not previously 
been examined. This is an important area to investigate 
as private hospitals account for approximately 40% of all 
hospitalisations in Australia31 and there are key demo-
graphic differences between public and private hospitals 
(eg, private hospitals have a higher percentage of surgical 
compared with medical patients31; patients of a higher 
socioeconomic status than public hospitals31; and more 
patients aged 55–74 are treated in private hospitals than 
other age groups32) which may impact the prevalence of 
frailty or pain in the private hospital setting.
The prevalence of pain in hospital settings is also not 
clearly understood. Clinical assessment of pain is tradi-
tionally reliant on patient self- reports using numeric 
ratings of pain intensity on a 0–10 scale33 or pain scales 
developed for use with patients with a cognitive decline, 
such as the Abbey Pain Scale.34 Prevalence studies inves-
tigating pain in hospitals have used similar tools but 
the time frames over which patients are asked to rate 
their pain have varied (eg, current pain vs any pain in 
the last 24 hours). In a systematic review, Gregory and 
McGowan11 identified five previous point prevalence 
studies of current pain across entire hospitals35–39 that 
reported rates of between 37.7% and 84%, and three 
studies of pain in the last 24 hours which reported rates 
between 52% and 65%.35 36 40 Given the self- report nature 
of the commonly used tools, pain can be difficult to 
accurately assess in patients with cognitive impairment, 
meaning these patients are routinely excluded from pain 
prevalence studies.35–37 39–42
In response to the problem of subjective pain assess-
ment in cognitively impaired individuals, PainChek has 
been developed and validated as an effective, technology 
driven, multimodal, multiplatform and hybrid, pain 
assessment tool. PainChek is a smart- device application 
that evaluates pain in adults in 1 min using automated 
facial recognition and analysis to identify pain- related 
facial microexpressions, together with a series of user 
completed checklists of pain behaviours.43 44 It uses the 
in- built cameras and processors of smart devices to assess 
the presence of pain- associated facial muscle movements 
using a 3 second video analysis of the individual’s face. The 
application then guides the assessor through checklists of 
pain behaviours, which include items related to changes 
in vocalisations, movement, and behaviours enacted by 
individuals during the experience of pain (figure 1). 
The total of these behaviours informs the pain intensity 
according to the following categories: no pain (0–6), mild 
(7–11), moderate (12–15) and severe (≥16).44 45 Based on 
a number of clinical studies (total participants n=74, 753 
paired pain assessments) the PainChek application has 
demonstrated sound psychometric validity and reliability 
and clinical utility in people with moderate- to- severe 
dementia.44–47 The prevalence of pain has not previously 
been assessed across an entire hospital using a technology 
driven assessment of pain. The use of such a device would 
allow data to be collected from all participants including 
those unable to provide a reliable self- report rating of 
their pain.
The aim of the proposed study is to conduct a point 
prevalence survey on frailty and pain of adult inpatients 
in an acute private hospital in Western Australia. The 
study will be the first worldwide to investigate the prev-
alence of frailty across the adult inpatients of an entire 
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acute private hospital (excluding patients in day surgery 
and critical care units), and the first across an entire 
Australian hospital. In addition, the proposed study will 
be the first point prevalence study of current pain across 
an entire hospital using a technology driven assessment 
of pain. Results of this study will provide an under-
standing of the distribution of frailty and pain and their 
concurrence across the hospital setting and guide future 
research into potential interventions.
METHODS AND ANALYSIS
Study design and setting
A prospective, observational, single- day point preva-
lence, cross- sectional study assessing frailty and pain 
will be undertaken. The study will be conducted across 
all non- critical care wards of an acute private metropol-
itan hospital in Perth, Western Australia. It is the largest 
private hospital in Western Australia with 738 licensed 
beds. The study will take place in late November 2020. 
The Strengthening the Reporting of Observational 
Studies in Epidemiology Statement Checklist will be used 
to report the findings of the study.48
Recruitment
Potential participants will include all adult inpatients who 
were hospitalised at or before 08:00 hours on the day of 
data collection, excluding day procedure, intensive care 
(ICUs) and coronary care units (CCUs). It is anticipated 
there will be a maximum of 518 participants across 18 
wards including surgical, medical, rehabilitation and 
mental health specialties. Participant inclusion and exclu-
sion criteria are:
Inclusion criteria
 ► All acute care inpatients willing and able to provide 
informed verbal consent.
 ► All acute care inpatients who are unable to consent 
due to cognitive impairment or inability to verbally 
communicate, and have written proxy consent 
provided.
 ► Aged 18 years or over.
Exclusion criteria
The patient will not participate in the study if any of the 
following apply:
 ► Admitted to day procedures unit.
 ► Admitted to high- dependency areas (ICU, CCU).
 ► Hospitalised after 08:00 hours.
 ► Severe hearing impairment.
 ► Severe intellectual disability.
 ► Too unwell to participate.
 ► Refuse consent.
Excluded patients will be noted and the reason for 
exclusion recorded. If a patient or proxy who is declining 
to participate volunteers a reason for their refusal that 
reason will also be recorded.
Participant information sheets will be provided to inpa-
tients in the 2 days prior to commencement of data collec-
tion. For patients admitted after 17:00 hours on the day 
prior to data collection the participant information sheet 
will be provided on the day of data collection.
Given the research is low risk, the interaction with the 
patient is minor, and assessments of pain and frailty are 
part of standard care, we will seek verbal consent from 
patients with their response recorded by the data collector. 
If a patient is unable to provide informed consent due 
to cognitive impairment or inability to verbally commu-
nicate, written proxy consent will be sought from their 
guardian or next- of- kin following guidelines from the 
Western Australian Department of Health to adhere to 
the requirements of the Western Australian Guardianship 
and Administration Amendment (Medical Research) 
Act 2020.49 On admission to the study site, patients are 
routinely assessed using the 4AT (Assessment Test) for 
delirium and cognitive impairment (4AT; www. the4at. 
com). For patients with a 4AT score of 4 or greater the 
data collector will check the patient’s file for a cognitive 
assessment (either the Mini- Mental State Examination50 
or Montreal Cognitive Assessment51 (MMSE, MoCA)). 
Where cognitive assessment indicates no cognitive impair-
ment (MMSE ≥25; MoCA >25) consent will be sought 
from the patient. Where cognitive assessment scores indi-
cate severe cognitive impairment (MMSE <18; MoCA <10) 
proxy consent will be sought. Where cognitive assessment 
indicates mild- moderate cognitive impairment (MMSE 
18–24; MoCA 10–25) or if no cognitive assessment has 
been performed the data collector will consult with the 
patient’s medical team to determine if the patient has the 
Figure 1 PainChek assess facial microexpressions that 
indicate the presence of pain. A pain intensity score is 
calculated across six domains of pain assessment. The face 
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capacity to consent or if proxy consent should be sought. 
If a patient is unable to speak English a telephone trans-
lation service will be used to interpret the information 
sheet, ask for consent and administer questionnaires.
Data collection
All data will be collected on a single day with approximately 
15 min interactions with each participant. Data collectors 
will work in pairs, with one data collector conducting the 
pain and frailty assessments with the patient (or proxy 
where necessary), while the other will access the patient’s 
file to record demographic and clinical information. 
Data collectors will be members of the research team, 
registered nurses from the study hospital and nursing 
students from the study university. All data collectors will 
be required to complete a 2- hour training session on the 
data collection protocol including the PainChek assess-
ment no more than 7 days prior to data collection. Both 
the mod- REFS and PainChek were developed for use by 
non- health professionals. Evidence from previous studies 
found excellent inter- rater reliability, on the REFS when 
administered by two non- medically trained research 
scientists,19 and PainChek when administered by nurses 
trained to administer the assessment,46 which suggests a 
single assessment of each patient is sufficient.
On the day of data collection, before approaching 
patients, the data collectors will meet with the ward nurse 
manager to obtain a bed list of patients currently admitted 
to the ward. The nurse manager will identify patients 
too unwell to participate and those with an intellectual 
disability, who will be excluded from the study. Prior to 
approaching a patient, the data collectors will check the 
patient’s 4AT score in the patient’s file (score <4 patient 
will be approached, score ≥4 cognitive assessments will be 
checked and proxy consent will be sought if required). If 
a patient is absent from their bed space, data collectors 
will return later in the day.
Each participant will have a pain and frailty assessment; 
demographic and clinical data will also be collected. 
During the pain and frailty assessments, data collectors 
will enter the participant’s responses into a data collection 
form in Qualtrics running on an iPad or iPad mini. Where 
consent is sought from a proxy, the pain assessment will 
be conducted with the patient only using PainChek, and 
the frailty assessment will be completed by the proxy on 
behalf of the patient.
Pain assessment
Current pain status will be assessed at rest for all partici-
pants using the PainChek application on an iPad or iPad 
mini. PainChek uses a combination of automated facial 
recognition and other clinical indicators to calculate a 
pain intensity score. The score is based on the summation 
of 42 indicators of pain across 6 domains (ie, Face, Voice, 
Movement, Behaviour, Activity, Body) the presence of 
which are scored as ‘yes’=1 and ‘no’=0. As part of its multi-
diamentional design, PainChek also captures specific data 
on pain interference, which cover physical, emotional and 
social aspects of pain experience. PainChek scores will be 
stored in the PainChek cloud repository and entered into 
the Qualtrics data collection form.
Following the PainChek assessment participants who 
are able to self- report pain (ie, those without cognitive 
decline) will be asked to give a numerical rating of the 
intensity of their current pain and the worst pain they have 
experienced in the last 24 hours. These will be conducted 
using the routine verbal 0–10 Numerical Rating Scale 
where 0 is ‘no pain at all’ and 10 is ‘worst possible pain’.
Frailty assessment
Frailty will be assessed using the mod- REFS which is a 
13- item self- report questionnaire scored from 0 to 18.20 
This tool was chosen as it is quick to administer (<10 min), 
can assess frailty prior to an acute illness, is validated for 
use in hospitals,20 and has previously been used to assess 
the point prevalence of frailty in a hospital setting.12 
Participants will be asked two additional questions on 
their perceptions of their own frailty: (1) Do you consider 
yourself to be frail? (yes/no) and (2) Based on the answer 
to the last question, on a scale of 0–10 where 0 is ‘not 
at all’ and 10 is ‘extremely’ how frail do you think you 
are? In the case of participants requiring proxy consent 
due to cognitive impairment the mod- REFS and frailty 
questions will be completed by the proxy on behalf of the 
participant.
Demographic and clinical data
Routine admission data will be collected from the patient 
files including year of birth, gender, admission date, 
indigenous status, admission type (elective or acute) and 
admission mode (home or residential aged- care facility). 
Clinical information including admitting diagnosis, active 
medical conditions and analgesics (name, dose and time 
of last dose) will also be collected from patient files.
Data reporting and analysis
The overall response rate of the survey will be reported 
as a percentage of eligible patients. Reasons for exclusion 
and the associated percentages will also be reported. The 
distributions of demographic and clinical characteristics 
will be described for the overall cohort using standard 
summary statistics.
The percentage prevalence of frailty in the sample will 
be calculated based on the mod- REFs score where a score 
of 8 and above is classified as frail, and will also be calcu-
lated in terms of the severity of frailty for the classifica-
tions: not frail (0–5), apparently vulnerable (6–7), mild 
frailty (8–9), moderate frailty (10–11) and severe frailty 
(12–18).20 Prevalence will be reported across the whole 
sample and by specialty (ie, medical, surgical, rehabilita-
tion, mental health). Comparison between scores on the 
mod- REFS and subjective perceptions of personal frailty 
obtained from supplementary questions will be explored 
(ie, do patients classified as severely frail on the mod- 
REFS classify themselves as frail more often, and rate 
their frailty higher, than those classified as moderately 
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frail). Demographics for frail vs not frail patients will be 
reported and explored.
Percentage prevalence of pain across the whole sample 
and by specialty will be calculated separately for PainChek 
scores (≤6 no pain, ≥7 pain),45 numerical ratings of 
current pain (0 no pain, ≥1 pain) and numerical ratings 
of worst pain in the last 24 hours (0 no pain, ≥1 pain). 
Demographic characteristics of the patients reporting 
pain vs no pain will be described and explored. Preva-
lence will also be explored in terms of intensity of pain 
for PainChek (0–6 no pain, 7–11 mild, 12–15 moderate 
and ≥16 severe)44 and the numerical ratings (1–4 mild, 
5–6 moderate, 7–10 severe).52
In accordance with the intention- to- treat principle, all 
available data from all participants will be included in the 
primary statistical analysis. The analysis will involve the 
use of regression models to identify important factors 
related to the prevalence of frailty and pain reporting 
point estimates and 95% CIs along with a p value of 0.05 
to determine the statistical significance of important risk 
factors. Analyses will be conducted using Stata V.16 IC.53
Data management
Data will be managed according to the Australian National 
Statement on Ethical Conduct in Human Research (2007). 
No identifying data will be collected. Participants will be 
assigned a participant number based on their ward and 
bed number. Hard copy data collection forms will be 
stored in locked filing cabinets at the university accessible 
only by research team members. The data and participant 
information collected will be stored securely on Univer-
sity servers only accessible by research team members on 
password protected computers. PainChek data will be 
stored in a repository within the PainChek secure cloud 
database. Data will only be accessible by the research team 
members via a password protected Web Administration 
Portal. Data may be made available to other researchers 
for future research and may be published online according 
to publisher’s requirements. All data will be destroyed after 
7 years.
Patient and public involvement
Patients at the site are represented by a consumer repre-
sentative from the hospital consumer advisory board. The 
consumer representative was invited to be part of the project 
at the commencement as a member of the research team 
and was involved in the study design. The research ques-
tions were discussed with the team and the proposal that 
included the research questions and outcome measures was 
reviewed by the team.
As we will not be collecting any personal or contact infor-
mation from the study participants, it will not be possible to 
disseminate the research findings to them directly. However, 
findings will be communicated via the hospital newsletter 
and national hospital group newsletter and the PainChek 
website. The consumer representative will be involved in 
the discussions about the dissemination plan.
ETHICS AND DISSEMINATION
Given the relationship between cognitive decline and 
frailty it is important to include patients with cognitive 
impairment in this study. Similarly, in order to measure 
prevalence across the entire hospital it is important to 
include inpatients admitted to the mental health wards. 
The inclusion of participants with cognitive impairment 
and mental illness requires particular consideration of the 
consent procedures and risk of distress for these patients as 
per the Australian National Statement on Ethical Conduct 
in Human Research (2007). Patients in the mental health 
wards of the study hospital are all admitted voluntarily and 
can provide informed consent. Any refusal to participate 
will be respected. Where cognitive impairment means a 
patient is unable to provide informed consent, consent will 
be sought from the patient’s legal guardian or next- of- kin. 
If at any point a patient exhibits signs of distress, the assess-
ment will cease, and nursing assistance will be sought.
This study has ethical approval from both the Ramsay 
Health Care Human Research Ethics Committee for 
Western Australia and South Australia (reference number: 
2038) and the Edith Cowan University Human Research 
Ethics Committee (reference: 2020–02008- SAUNDERS).
Results of this study will be disseminated at a number of 
levels. A report of the study findings will be provided to the 
study hospital and may be used to review its procedures and 
to guide a larger prevalence study across all hospitals run 
by the operator in Australia. Regardless of the outcomes, 
it is our intention to publish the results of this study in a 
peer- reviewed journal. Findings will also be presented at 
Australian and international conferences. Publications 
resulting from this study will be publicised through project 
and departmental social media.
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